Provided by Tiger Trade Technology Pte. Ltd.

Genprex, Inc.

2.27
+0.490027.53%
Post-market: 2.26-0.0100-0.44%16:26 EST
Volume:9.15M
Turnover:20.14M
Market Cap:5.26M
PE:-0.06
High:2.42
Open:1.92
Low:1.84
Close:1.78
52wk High:55.00
52wk Low:1.71
Shares:2.32M
Float Shares:2.27M
Volume Ratio:50.81
T/O Rate:403.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-37.3218
EPS(LYR):-266.9534
ROE:-1401.39%
ROA:-273.31%
PB:6.86
PE(LYR):-0.01

Loading ...

Genprex granted Japanese and EU patents for Reqorsa Gene Therapy

TIPRANKS
·
Yesterday

Genprex Wins Japanese and European Patent Grants for Reqorsa Gene Therapy Combinations With PD-1/PD-L1 Immunotherapies

Reuters
·
Yesterday

Genprex erhält Patenterteilungsankündigung für Reqorsa-Gentherapie-Kombination in Australien

Reuters
·
Feb 10

Genprex Announces Ip Australia's Intent to Grant Patent for Reqorsa® Gene Therapy in Combination With Pd-L1 Antibodies to Treat Cancers

THOMSON REUTERS
·
Feb 10

Genprex Faces Nasdaq Delisting Risk if Equity Compliance Lapses Within Monitoring Period

Reuters
·
Jan 10

Congressman Who Was Top 2025 Stock Picker Buys Shares Of $5M Company You've Never Heard Of

Benzinga_recent_news
·
Jan 10

Genprex Reports Positive Preclinical Results for Diabetes Gene Therapy Candidate

Reuters
·
Jan 07

Genprex Provides Clinical Update on Diabetes Gene Therapy Program

THOMSON REUTERS
·
Jan 07

BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin

Reuters
·
Jan 06

BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge

Reuters
·
Jan 06

BUZZ-Genprex rises as diabetes gene therapy shows promise in animal tests

Reuters
·
Jan 06

Genprex Reports Positive Preclinical Results for GPX-002 Diabetes Gene Therapy

Reuters
·
Jan 06

Genprex Announces Positive Preliminary Preclinical Data From Study of Gpx-002 in Type 2 Diabetic Animal Studies

THOMSON REUTERS
·
Jan 06

Genprex Faces Nasdaq Listing Uncertainty Over Stockholders' Equity Compliance

Reuters
·
Dec 23, 2025

Congressman Buys Shares Of Small Cap Lift Truck Company You've Probably Never Heard Of

Benzinga_recent_news
·
Dec 05, 2025

Genprex Faces Nasdaq Delisting Risk Over Compliance Shortfalls

Reuters
·
Nov 26, 2025

Data From Genprex's Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer

THOMSON REUTERS
·
Nov 24, 2025

Genprex files to sell 1.28M shares of common stock for holders

TIPRANKS
·
Nov 22, 2025

Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lung Cancer Clinical Trials

THOMSON REUTERS
·
Nov 19, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Energizer Holdings, Target

Reuters
·
Nov 19, 2025